Sujuan Ding

Gut Microbiota-Derived β-Glucuronidase Governs the Anticolitic Efficacy of Daidzein via the ERβ-PI3K/Akt/mTOR-Autophagy Axis

Precision nutritional interventions targeting the gut microenvironment have emerged as a pivotal strategy for managing inflammatory bowel disease (IBD). However, the specific microbial mechanisms governing the therapeutic efficacy of dietary flavonoids, such as daidzein (DA), remain largely unexplored. In this study,...

Viral–Gut Microbiota Interactions: Implications for the Gut Mucosa in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), arises from complex interactions among genetic susceptibility, immune dysregulation, environmental factors, and the gut microbiome. Bacterial dysbiosis has been extensively studied, whereas the gut virome—comprising eukaryotic...

The Gut-Brain Axis and Neurodegenerative Diseases: From Mechanistic Pathways to Therapeutic Interventions.

Molecular Mechanisms and Current Research Status of Salvianolic Acid B in the Treatment of Cardiovascular Diseases.

This review comprehensively summarizes the pharmacological effects, research progress and molecular mechanisms of Sal B cardiovascular protection, focusing on six aspects: antioxidant effect, anti-inflammatory activity, endothelial protective function, antifibrotic properties, inhibition of platelet aggregation and car...